Advertisement

Endoscopic Treatment of Esophageal Varices: Selection of Treatment Method

  • Katsutoshi ObaraEmail author
Chapter

Abstract

In Japan, endoscopic treatment, which includes endoscopic injection sclerotherapy and endoscopic variceal ligation, is the first-line treatment for esophageal varices. However, as both of these methods have their respective pros and cons, individual patient conditions and portal hemodynamics must be fully studied so that an optimal treatment method can be selected for each patient. More precisely, the patient conditions that need to be studied include the residual liver function and the presence of hepatocellular carcinoma. In addition, endoscopic ultrasonography is useful for studying the portal hemodynamics in the immediate surroundings of varices, while three-dimensional computed tomography is useful for studying the overall portal region. Recently, high-resolution imaging of endoscopic ultrasonography has made it possible to evaluate the development of periesophageal veins and perforating veins, which also contributes to the selection of an optimal treatment method.

Keywords

Esophageal varices Endoscopic injection sclerotherapy Endoscopic variceal ligation EUS MDCT 

References

  1. 1.
    Kimoto S, Sugie S. Diagnosis and treatment of portal hypertension. Nihon Geka Gakkai Zasshi (J Jpn Surg Soc). 1956;57:1097–103. [In Japanese].Google Scholar
  2. 2.
    Sugiura M, Ichihara S, Nomura M, et al. Surgical treatment of portal hypertension. Jpn Med J. 1970;2417:7–14. [In Japanese].Google Scholar
  3. 3.
    Takase Y, Iwasaki Y, Haebaru H, et al. Endoscopic injection therapy of esophageal varices using fiberscopes. Prog Dig Endosc. 1978;12:105–8. [In Japanese].Google Scholar
  4. 4.
    Suzuki H, Nagao F. Endoscopic injection sclerotherapy: procedures, indications and outcomes. Seijinbyo to Seikatsushukanbyo (J Adult Dis). 1981;12:2307–11. [In Japanese].Google Scholar
  5. 5.
    Obara K, Masaki M, Sakamoto H, Iwasaki K, Mitsuhashi H, Orikasa K, et al. Studies on prognosis of patients with esophageal and gastric varices treated with injection sclerotherapy using EO or EO-AS combination method. Gastroenterol Endosc. 1987;29:2232–6. [In Japanese with English abstract].Google Scholar
  6. 6.
    Makuuchi H, Tanaka Y, Sugiura K, et al. Endoscopic injection sclerotherapy for esophagogastric varices: ETP method and prognosis. Stomach Intestine. 1985;20:497–505. [In Japanese].Google Scholar
  7. 7.
    Kitano S, Koyanagi N, Iso Y, Higashi H, Sugimachi K. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology. 1987;7:810–5.PubMedCentralCrossRefGoogle Scholar
  8. 8.
    Deguchi H, Kato J, Maeda Y, Moribata K, Shingaki N, Niwa T, et al. Argon plasma coagulation is effective for prevention of recurrent esophageal varices after endoscopic injection sclerotherapy: single-center case-control study. Dig Endosc. 2016;28:42–9.  https://doi.org/10.1111/den.12538.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Obara K, Ohira H, Sakamoto H, Iwasaki K, Mitsuhashi M, Suzuki S, et al. A new method of sclerotherapy for esophagogastric varices: EO-AS combination method followed by mucosa-fibrosis with AS. Gastroenterol Endosc. 1981;31:2977–81. [In Japanese with English abstract].Google Scholar
  10. 10.
    Obara K, Kojima T, Irisawa A, Watanabe S, Kuwana T, Kogure A, et al. A new method of sclerotherapy for esophageal varices: EO-AS combination method followed by mucosa-fibrosing with laser. Gastroenterol Endosc. 1994;36:716–21. [In Japanese with English abstract].Google Scholar
  11. 11.
    Nakamura S, Mitsunaga A, Murata Y, Suzuki S, Hayashi N. Endoscopic induction of mucosal fibrosis by argon plasma coagulation (APC) for esophageal varices: a prospective randomized trial of ligation plus APC vs. Ligation alone. Endoscopy. 2001;33(3):210–5.CrossRefGoogle Scholar
  12. 12.
    Stiegmann GV, Goff JS, Sun JH, Wilbon S. Endoscopic elastic band ligation for active variceal hemorrhage. Am Surg. 1989;55(2):124–8.PubMedGoogle Scholar
  13. 13.
    Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition.). Dig Endosc. 2010;22:1–9.  https://doi.org/10.1111/j.1443-1661.2009.00929.x.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    The Japan Society for Portal Hypertension. The general rules for study of portal hypertension. 3rd ed. Tokyo: Kanehara & Co., Ltd; 2013. [In Japanese].Google Scholar
  15. 15.
    Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51:629–50.  https://doi.org/10.1007/s00535-016-1216-y.CrossRefPubMedGoogle Scholar
  16. 16.
    Obara K, Toyonaga A, Kokubu S. Guidelines for the endoscopic treatment of esophagogastric varices. In: Society for Japanese Gastroenterological Endoscopy, editor. Guidelines for gastrointestinal endoscopy. 3rd ed. Tokyo: Igaku-Shoin; 2006. p. 215–34. [In Japanese].Google Scholar
  17. 17.
    The American Society for Gastrointestinal Endoscopy. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80(2):221–7.CrossRefGoogle Scholar
  18. 18.
    de Franchis R, Baveno IV Faculty. Expanding consensus in portal hypertension. Report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–52.Google Scholar
  19. 19.
    Gotoh Y, Iwakiri R, Sakata Y, Koyama T, Noda T, Matsunaga C, et al. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled tiral compared with endoscopic injection sclerotherapy. J Gastroenterol Hepatol. 1999;14(3):241–4.PubMedCentralCrossRefGoogle Scholar
  20. 20.
    Ogusu T, Iwakiri R, Sakata H, Matsunaga K, Shimoda R, Oda K, et al. Endoscopic injection sclerotherapy for esophageal varices in cirrhotic patitents without hepatocellular carcinoma: a comparison of longterm survival between prophylactic therapy and emergency therapy. J Gastroenterol. 2003;38(4):361–4.CrossRefGoogle Scholar
  21. 21.
    Naritaka Y, Shimakawa T, Isohata N, Asaka S, Konno S, Murayama M, et al. Long-term results of endoscopic injection sclerotherapy in 602 patients with esophageal varices. Hepatogastroenterology. 2008;55(88):2096–102.PubMedGoogle Scholar
  22. 22.
    Iso Y, Kawanaka H, Tomikawa M, Matsumata T, Kitano S, Sugimachi K. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices: a prospective randomized trial. Hepatogastroenterology. 1997;44:467–71.PubMedGoogle Scholar
  23. 23.
    Westaby D, Poison RJ, Gimson AE, Hayes PC, Hayllar K, Williams R. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of varieal bleeding. Hepatology. 1990;11:353–9.CrossRefGoogle Scholar
  24. 24.
    Svoboda P, Kantorova OJ, Kozumplik L, Marsova J. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices. Surg Endosc. 1999;13(6):580–4.CrossRefGoogle Scholar
  25. 25.
    Krige JE, Bornman PC, Goldberg PA, Terblanche J. Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients. Arch Surg. 2000;135(11):1315–22.CrossRefGoogle Scholar
  26. 26.
    Krige JE, Kotze UK, Bornman PC, Shaw JM, Klipin M. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg. 2006;244(5):764–70.PubMedCentralCrossRefGoogle Scholar
  27. 27.
    Obara K. Endoscopic EV treatment. Endoscopic treatment of esophagogastric varices. Tokyo: Narunia Inc.; 2016. p. 21–7.Google Scholar
  28. 28.
    The Japanese Society of Gastroenterology. Evidence-based clinical practice guidelines for liver cirrhosis 2015. 2nd ed. Tokyo: Nankodo Co., Ltd.; 2015. p. 78–9. [In Japanese].Google Scholar
  29. 29.
    The Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, second English edition. Tokyo: Kanehara & Co., Ltd; 2003.Google Scholar
  30. 30.
    Akahoshi T, Tomikawa M, Tsutsumi N, Hshizume M, Maehara Y. Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma: prospective randomized study. Dig Endosc. 2014;26:172–7.PubMedCentralCrossRefGoogle Scholar
  31. 31.
    Murashima N, Arase Y, Ikeda K, Chayama K, Saitoh S, Suzuki Y, et al. Endoscopic regression and evaluation of injection sclerotherapy for esophageal varices in case of hepatocellular carcinoma with portal vein invasion. Gastroenterol Endosc. 1996;38(10):2379–85. [In Japanese with English abstract].Google Scholar
  32. 32.
    Kawai T, Yashima Y, Sugimoto T, Sato T, Kanda M, Endo N, et al. Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study. World J Surg Oncol. 2016;14:52.  https://doi.org/10.1186/s12957-016-0802-z.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Hayashi S, Saeki S. Clinical evaluation of endoscopical treatment for esophago-gastric varices in patients with tumor invasion in the portal vein trunk or first portal branches associated with hepatocellular carcinoma. Jpn J Port Hypertens. 1999;5:183–8. [In Japanese with English abstract].Google Scholar
  34. 34.
    Toyonaga A. Pathogenesis and clinical physiology of esophagogastric varices. In: Esophagogastric varices. 3rd ed. Supervised by Obara K and Suzuki H. Tokyo: Nihon Medical Center; 2012. p. 21–8. [In Japanese].Google Scholar
  35. 35.
    Irisawa A, Obara K, Sato Y, Saito A, Takiguti F, Shishido H, Sakamoto H, et al. EUS analysis of collateral veins inside and outside the esophageal wall in portal hypertension. Gastrointest Endosc. 1999;50:374–80.PubMedCentralCrossRefGoogle Scholar
  36. 36.
    Obara K, Irisawa A, Sato Y. Usefulness of EUS in portal hypertension with esophageal varices. Dig Endosc. 2004;16(Suppl 2):S168–72.CrossRefGoogle Scholar
  37. 37.
    Irisawa A, Saito A, Obara K, Shibukawa G, Takagi T, Shishido H, et al. Endosopic recurrence of esophageal varices is associated with the specific EUS abnormalities: severe periesophageal collateral veins and large perforating veins. Gastrointest Endosc. 2001;53:77–84.PubMedCentralCrossRefGoogle Scholar
  38. 38.
    Nakamura S, Murata Y, Mitsunaga AI, Hayashi N, Suzuki S. Hemodynamics of esophageal varices on three-dimensional endoscopic ultrasonography and indication of endoscopic variceal ligation. Dig Endosc. 2003;15:289–97.CrossRefGoogle Scholar
  39. 39.
    Hino S, Kakutani H, Ikeda K, Uchiyama Y, Sumiyama K, Kuramochi A, et al. Hemodynamic assessment of the left gastric vein in patients with esophageal varices with color doppler EUS: factors affecting development of esophageal varices. Gastrointest Endosc. 2002;55(4):512–7.CrossRefGoogle Scholar
  40. 40.
    Shimizu T, Namba R, Matsuoka T, Tabuchi K, Ymamoto K, Umesugi Y, et al. Esophageal varices before and after endoscopic variceal ligation: evaluation using helical CT. Eur Radiol. 1999;9:1546–9.CrossRefGoogle Scholar
  41. 41.
    Mifune H, Akaki S, Ida K, Sei T, Kanazawa S, Okada H. Evaluation of esophageal varices by multidetector-row CT: correlation with endoscopic ‘red color sign’. Acta Med Okayama. 2007;61:247–54.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Advanced Gastrointestinal EndoscopyFukushima Medical UniversityFukushimaJapan

Personalised recommendations